Leslie Andritsos

Leslie Andritsos

UNVERIFIED PROFILE

Are you Leslie Andritsos?   Register this Author

Register author
Leslie Andritsos

Leslie Andritsos

Publications by authors named "Leslie Andritsos"

Are you Leslie Andritsos?   Register this Author

86Publications

2967Reads

29Profile Views

A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia.

Leuk Lymphoma 2019 Dec 27;60(14):3461-3469. Epub 2019 Jul 27.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1643463DOI Listing
December 2019

Spontaneous resolution of untreated diffuse large B-cell lymphoma of maxillary bone after incisional biopsy.

Clin Case Rep 2019 Nov 27;7(11):2082-2086. Epub 2019 Sep 27.

University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.2408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878081PMC
November 2019

Ruxolitinib In The Treatment Of Polycythemia Vera: An Update On Health-Related Quality Of Life And Patient-Reported Outcomes.

J Blood Med 2019 14;10:381-390. Epub 2019 Nov 14.

University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JBM.S177692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861552PMC
November 2019

Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.

Leuk Res 2019 Oct 9;85:106215. Epub 2019 Aug 9.

University of Arizona Cancer Center, Tucson, AZ, USA; Department of Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USA; Banner University Medical Center, Tucson, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106215DOI Listing
October 2019

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Leuk Lymphoma 2019 Sep 15;60(9):2223-2229. Epub 2019 Feb 15.

Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573996DOI Listing
September 2019

Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues.

J Am Acad Dermatol 2019 06 8;80(6):1762-1764. Epub 2018 Sep 8.

Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2018.07.066DOI Listing
June 2019

Cutaneous adverse events associated with purine analogs in the treatment of hairy cell leukemia.

Int J Dermatol 2019 May 27;58(5):e109-e110. Epub 2018 Nov 27.

Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.14320DOI Listing
May 2019

Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy.

Leuk Lymphoma 2018 06 13;59(6):1498-1500. Epub 2017 Sep 13.

c Divison of Hematology , The Ohio State University , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1376744DOI Listing
June 2018

A retrospective review of fall risk factors in the bone marrow transplant inpatient service.

J Oncol Pharm Pract 2018 Jun 16;24(4):272-280. Epub 2017 Mar 16.

4 The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217697485DOI Listing
June 2018

The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.

Cancer Med 2017 Apr 15;6(4):778-787. Epub 2017 Mar 15.

Division of Hematology, Department of Internal Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387133PMC
April 2017

Tocilizumab for steroid refractory acute graft-versus-host disease.

Leuk Lymphoma 2016 3;57(1):81-5. Epub 2015 Jul 3.

b Division of Hematology, Department of Internal Medicine , James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1045896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698359PMC
October 2016

A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy.

Ann Hematol 2016 Jun 27;95(7):1137-43. Epub 2016 Apr 27.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 320 W. 10th Avenue, Columbus, Ohio, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2683-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981588PMC
June 2016

Ibrutinib for treatment of chronic lymphocytic leukemia.

Am J Health Syst Pharm 2016 Mar;73(6):367-75

Division of Hematology, Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Solove Research Institute, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp140760DOI Listing
March 2016

Historical overview of hairy cell leukemia.

Best Pract Res Clin Haematol 2015 Dec 26;28(4):166-74. Epub 2015 Oct 26.

Department of Internal Medicine, The Ohio State University, 395 W 12th Avenue #392, Columbus, OH 43210, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2015.10.018DOI Listing
December 2015

Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).

Am J Hematol 2015 Apr 25;90(4):327-33. Epub 2015 Feb 25.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Comprehensive Cancer Center, The Ohio State University, College of Pharmacy, The Ohio State University, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552311PMC
April 2015

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.

Proc Natl Acad Sci U S A 2015 Apr 18;112(14):4322-7. Epub 2015 Mar 18.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210; College of Pharmacy, The Ohio State University, Columbus, OH 43210

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1503587112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394264PMC
April 2015

OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.

Blood 2015 Jan 7;125(2):284-95. Epub 2014 Oct 7.

Department of Internal Medicine, Division of Hematology, Wexner Medical Center, Department of Medical Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-06-583518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287637PMC
January 2015

Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.

J Natl Compr Canc Netw 2015 Jan;13(1):9-13; quiz 13

From the Division of Hematology, Department of Internal Medicine, Department of Pathology, and Division of Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0004DOI Listing
January 2015

A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia.

Leuk Res 2014 Sep 29;38(9):1025-9. Epub 2014 May 29.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA; Comprehensive Cancer Center, The Ohio State University, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.05.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312491PMC
September 2014

Hairy cell leukemia: Update on molecular profiling and therapeutic advances.

Blood Rev 2014 Sep 11;28(5):197-203. Epub 2014 Jul 11.

320 W. 10th Ave, A352 Starling Loving Hall, Columbus, OH 43210, USA; Department of Internal Medicine, Division of Hematology at The Ohio State University, Columbus, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2014.06.003DOI Listing
September 2014

Multifocal epithelial hyperplasia (Heck disease) in a patient with chronic lymphocytic leukemia.

J Cutan Pathol 2014 Aug 22;41(8):694-6. Epub 2014 Apr 22.

Ohio State University College of Medicine, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12341DOI Listing
August 2014

Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation.

J Am Acad Dermatol 2013 Mar 12;68(3):489-92. Epub 2012 Sep 12.

Dermatology, Ohio State University College of Medicine, Columbus, Ohio 43216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2012.08.021DOI Listing
March 2013

Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia.

Case Rep Hematol 2012 7;2012:589718. Epub 2012 Nov 7.

Division of Hematology, The Arthur G. James Comprehensive Cancer Center and The Ohio State University, 320 W 10th Avenue, B354 Starling Loving Hall, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/589718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502771PMC
December 2012

Salvage therapy for relapsed chronic lymphocytic leukemia.

Expert Rev Hematol 2011 Apr;4(2):199-212

The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.11.13DOI Listing
April 2011

Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus.

Br J Haematol 2010 May 8;149(3):388-90. Epub 2010 Mar 8.

Division of Haematology and Oncology, The Ohio State University Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2010.08110.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038061PMC
May 2010

Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.

J Med Virol 2004 Sep;74(1):94-101

Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch at Galveston, 77555-0435, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.20151DOI Listing
September 2004

Chronic lymphocytic leukemia.

Curr Treat Options Oncol 2002 Jun;3(3):225-31

Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University, 660 South Euclid Avenue, Campus Box 8056, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-002-0012-5DOI Listing
June 2002